Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yujin Injection is a Traditional Chinese Medicine (TCM) injection developed and manufactured by Shanhaidan Pharmaceutical. It is a sterile aqueous solution derived from the extracts of *Houttuynia cordata* (Yuxingcao) and *Lonicera japonica* (Jinyinhua). The product is primarily indicated for the treatment of respiratory ailments, including upper respiratory tract infections, bronchopneumonia, and viral pneumonia, leveraging the traditional heat-clearing and detoxifying properties of its herbal constituents. Pharmacologically, the injection exhibits anti-inflammatory, antibacterial, and antiviral activities. These effects are attributed to active compounds such as quercetin and chlorogenic acid, which modulate inflammatory cytokines and interfere with viral replication processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yujin injection.